Seller record · Telehealth service

Livea

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 3 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named. The GLP-1 page and the answers refer only to accredited compounding pharmacies, 503B outsourcing facilities and state-licensed 503A pharmacies. 2 more criteria also fail; see the table below.

At a glance

LiveaTelehealth service

5/8criteria passed

Price: Semaglutide from $99 a month, tirzepatide from $199 when available
Sells: compounded semaglutide, compounded tirzepatide, GLP-1 microdosing, and 6 more
FDA letters: None on file

Visit Livea See all eight dispositions

Telehealth service. Passes 5 of 8 criteria. Recorded against Standard v1.1.

A Minnesota medical weight loss chain with six clinics plus telehealth care, selling compounded semaglutide and tirzepatide, a microdosing program, NAD+ therapy, hormone therapy and dietitian programs. Care starts with a free consultation in a clinic or by video, and no pharmacy is named.

Operating entity Minnesota Weight Control, Inc.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Livea's GLP-1 page; Livea's website; Livea's terms of service page
S2	Prescription gating	PASS	Livea's website; Livea's GLP-1 page; Livea's telehealth program page
S3	Pharmacy identification	FAIL	Livea's GLP-1 page; Livea's FAQ
S4	Compounding disclosure	FAIL	Livea's GLP-1 page; Livea's FAQ; Livea's terms of service page
S5	Analytical documentation	FAIL	Livea's GLP-1 page; Livea's FAQ; Livea's terms of service page
S6	Business address	PASS	Livea's terms of service page; Livea's privacy policy; Livea's locations page
S7	Price disclosure	PASS	Livea's GLP-1 page; Livea's FAQ; Livea's medical page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSAll medical services are provided by Livea Medical, PLLC, a physician-owned practice, and the GLP-1 page says a medical director, nurse practitioners and nurses review each patient's health history before any prescription is written.Source: Livea's GLP-1 page; Livea's website; Livea's terms of service page.

S2PASSEvery start button leads to a booking page for a free consultation, in a clinic or by telehealth, where the medical team reviews health history and eligibility before any prescription, and no page describes a payment step before that visit.Source: Livea's website; Livea's GLP-1 page; Livea's telehealth program page.

S3FAILNo filling pharmacy is named. The GLP-1 page and the answers refer only to accredited compounding pharmacies, 503B outsourcing facilities and state-licensed 503A pharmacies.Source: Livea's GLP-1 page; Livea's FAQ.

S4FAILThe GLP-1 page sells compounded semaglutide and tirzepatide, and no page, including the answers, the terms and the privacy policy, states that compounded medications are not FDA-approved; the answers say compounded GLP-1 medications are considered safe when sourced and prescribed responsibly.Source: Livea's GLP-1 page; Livea's FAQ; Livea's terms of service page.

S5FAILNo certificate of analysis or lot document is published on the GLP-1 page, the answers, the terms or the privacy policy.Source: Livea's GLP-1 page; Livea's FAQ; Livea's terms of service page.

S6PASSLivea Medical PLLC at 3495 Northdale Blvd, Ste 100, Coon Rapids, MN 55448, printed as the principal address in the terms and in the privacy policy, and the footer says the practice is managed by Minnesota Weight Control, Inc., doing business as Livea. The locations page lists the same address among six Minnesota clinics. The terms name Minnesota law.Source: Livea's terms of service page; Livea's privacy policy; Livea's locations page.

S7PASSCompounded semaglutide from $99 a month and compounded tirzepatide from $199 a month when available, on the GLP-1 page. The answers and the medical weight loss page instead say plans start at $69 a month, which the medical weight loss page says covers program access and medical supervision, with medication costs discussed at the consultation.Source: Livea's GLP-1 page; Livea's FAQ; Livea's medical page.

S8PASSNo FDA warning letter names Livea, Livea Medical, PLLC or Minnesota Weight Control, Inc., and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, GLP-1 microdosing, NAD+, Lipo-B12, bioidentical hormone therapy, testosterone therapy, Dysport, nutrition and dietitian services.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells NAD+

Visit Livea

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.